Disseminated Intravascular Coagulation (DIC) in Obstetric Practice

Disseminated intravascular coagulation (DIC) is an acquired and complex disorder that occurs in a wide variety of clinical conditions. This is basically a state of increased propensity for clot formation triggered by a variety of stimuli related to such diverse disorders as sepsis, endothelial cell damage (heat stroke, shock), obstetrical complication (abruptio placenta, amniotic fluid embolism, severe preeclampsia and retained intrauterine dead foetus) and neoplasm. DIC is a classic complication of obstetric conditions occurring in more than 50 percent of patients with obstetric causes. In DIC, an unregulated thrombin explosion cause release of free thrombin into the circulation that leads to the clinical features of DIC, with thrombin and plasmin responsible for the thrombotic and haemorrhagic manifestations, respectively. The diagnosis and treatment of this syndrome require an understanding of its pathophysiology, awareness of the disorders that can trigger it and its early recognition. Acute DIC is usually associated with infections, the commonest cause, about 10-20% of patients with gram negative sepsis have evidence of DIC. Chronic DIC is usually associated with retained dead fetus, carcinomatosis. The diagnosis of this syndrome is essentially clinical, with laboratory tests providing confirmatory evidence. Microvascular thrombosis is the primary mechanism in most cases, and end organ failure is a major cause of death. No single diagnostic test exists for DIC. DIC is initially suggested by the following combination; a clinical condition consistent with DIC, thrombocytopenia, prolonged PT, APTT, and presence of FDP/D-dimer. Medical treatment depends on the cause of the DIC. Basically it involves removing the cause for example, delivery of placenta if it is retained or abrupted, delivery of foetus if retained, quick delivery if severe eclampsia and so on, hysterectomy if bleeding can not be controlled from placental site. After then, and/or con-currently treat DIC with blood and plasma transfusions and appropriate supportive measures. As the sequel of DIC can be devastating, early clinical suspicion and laboratory diagnosis are essential. This review article provides essential guideline for the appropriate diagnosis and clinical management of DIC in obstetric patients. Key words: Disseminated intravascular coagulation (DIC); Obstetric; Thrombosis; Fibrin; Ddimer; FDP; Anticoagulant. DOI: http://dx.doi.org/10.3329/jdmc.v20i1.8585 J Dhaka Med Coll. 2011; 20(1) :68-74

[1]  M. Fejgin,et al.  Low molecular weight heparins and their use in obstetrics and gynecology. , 1994, Obstetrical & gynecological survey.

[2]  F. Ofosu,et al.  Thrombin Regulation in Mother and Fetus During Pregnancy , 1992, Seminars in thrombosis and hemostasis.

[3]  Chatelain Sm,et al.  Amniotic and thromboembolism. , 1990 .

[4]  P. Brill-Edwards,et al.  Heparin therapy during pregnancy. Risks to the fetus and mother. , 1989, Archives of internal medicine.

[5]  J. M. Carr,et al.  Diagnosis of disseminated intravascular coagulation. Role of D-dimer. , 1989, American journal of clinical pathology.

[6]  J. Alperin Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. , 1987, JAMA.

[7]  C. Weiner,et al.  The obstetric patient and disseminated intravascular coagulation. , 1986, Clinics in perinatology.

[8]  F. Montz,et al.  Hemodynamic alterations associated with amniotic fluid embolism: a reappraisal. , 1985, American journal of obstetrics and gynecology.

[9]  B. Sibai,et al.  Pregnancy Outcome in 303 Cases With Severe Preeclampsia , 1984, Obstetrics and gynecology.

[10]  D. Feinstein Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy , 1982 .

[11]  E. Plow Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. , 1982, The Journal of clinical investigation.

[12]  S. Gitel,et al.  Heparin: new concepts relevant to clinical use. , 1979, Blood.

[13]  G. Sher Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy. , 1977, American journal of obstetrics and gynecology.

[14]  W. G. Aken,et al.  Stimulation of Monocyte Procoagulant Activity by Adherence to Different Surfaces , 1977, Thrombosis and Haemostasis.

[15]  R. Bick Disseminated intravascular coagulation. , 1977, Hematology/oncology clinics of North America.

[16]  J. Corrigan,et al.  The association of maternal and neonatal thrombocytopenia in high-risk pregnancies. , 1977, American journal of obstetrics and gynecology.

[17]  C. Ballard,et al.  Consumptive Coagulopathy Associated With Intraamniotic Saline Instillation and the Effect of Intravenous Oxytocin , 1974, Obstetrics and gynecology.

[18]  J. Corrigan,et al.  Heparin therapy in septicemia with disseminated intravascular coagulation. , 1970, The New England journal of medicine.

[19]  R. Cowley,et al.  Alterations in coagulation and fibrinolytic mechanisms in acute trauma. , 1969, The Journal of trauma.

[20]  D. Mckay Trauma and disseminated intravascular coagulation. , 1969, The Journal of trauma.

[21]  G. Stewart,et al.  THE EFFECTS OF ENDOTOXIN ON VASCULAR ENDOTHELIUM , 1969, The Journal of experimental medicine.

[22]  C. Merskey,et al.  The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis , 1967, British journal of haematology.

[23]  S. Kohl,et al.  [Fetal death in utero]. , 1957, American journal of obstetrics and gynecology.

[24]  A. Sharp,et al.  Diagnosis of disseminated intravascular coagulation. , 1983, Bibliotheca haematologica.

[25]  D. Feinstein Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. , 1982, Blood.